Ticagrelor: all 294 studies that test it
Page 3 of 3. Open to participants first (27), then studies with results posted, then the rest; newest registration first within each.
- A Multicenter Trial to Assess the MIcrovascular Integrity and Left Ventricular Function Recovery After Clopidogrel or TicagrelOr Administration, in Patients With STEMI Treated With Thrombolysis - The 'MIRTOS' StudyCompletedNCT02429271Phase 3
- Role of Immune Responses After Acute Myocardial InfarctionStatus unknownNCT02428374Phase 4
- Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by TicagrelorStatus unknownNCT02422888Phase 4
- Safety and Efficacy of Low-Dose Ticagrelor in Chinese Patients With NSTE-ACSStatus unknownNCT02415803Phase 3
- Ticagrelor and Peripheral Arterial DiseaseTerminatedNCT02407314Phase 4
- Ticagrelor and Anti-inflammatory EffectsStatus unknownNCT02406911Phase 3
- Genotype and Platelet Reactivity in Patients on HemodialysisStatus unknownNCT02394145Phase 3
- Reversal of the Anti-platelet Effects of TicagrelorCompletedNCT02383771Phase 4
- Effect of Ticagrelor Versus Clopidogrel on Endothelial Dysfunction and Vascular InflammationStatus unknownNCT02379676Phase 4
- The Effect Of Ticagrelor On Saphenous Vein Graft Patency In Patients Undergoing Coronary Artery Bypass Grafting SurgeryStatus unknownNCT02352402Phase 3
- Effects and Plasma Concentration of Ticagrelor, After Crushed and Non-crushed Intake, After Acute Coronary SyndromeCompletedNCT02341729Phase 4
- A Single-center, Prospective,Randomized Study of Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Dual Anti-platelet Therapy After Coronary Artery Bypass GraftingCompletedNCT02330640Phase 4
- Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary SyndromesCompletedNCT02319941Phase 2
- Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtientsWithdrawnNCT02302508Phase 4
- Ticagrelor in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological ThrombolysisCompletedNCT02298088Phase 3
- High "on Treatment" Platelet Reactivity in the Intensive Care UnitStatus unknownNCT02285751Phase 2
- Effect of Ticagrelor on Adenosine-Induced Coronary Flow Reserve in Patients With Microvascular AnginaStatus unknownNCT02284048Phase 4
- Ticagrelor and Endothelial FunctionStatus unknownNCT02261922Phase 4
- Ticagrelor and Clopidogrel on Reperfusion in Patients With AMIStatus unknownNCT02233790Phase 4
- Ticagrelor Versus Clopidogrel in Left Ventricular Remodeling After ST-segment Elevation Myocardial InfarctionStatus unknownNCT02224534Phase 4
- Platelet Reactivity After TAVI: A Multicenter Pilot StudyCompletedNCT02224066Phase 4
- Sampling P2Y12 Receptor Inhibition With Prasugrel and Ticagrelor in Patients Submitted to ThrombolysisCompletedNCT02215993Phase 4
- TIcaGrEloR and ABSORB Bioresorbable Vascular Scaffold Implantation for Recovery of Vascular Function After Successful Chronic Total Occlusion RecanalizationCompletedNCT02211066Phase 4
- Safety of "Ticagrelor+ Warfarin"in Comparison With "Clopidogrel+Aspirin+Warfarin"CompletedNCT02206815Phase 4
- Efficacy of Ticagrelor vs Clopidogrel in High-risk NSTE-ACS Patients Undergoing Early PCIStatus unknownNCT02201667Phase 4
- Is Efficacy of PLAtelet Aggregation Inhibition by Ticagrelor Mediated P2Y12 Blockade Dependent Upon Endogenous Endothelial Nitric OXide?CompletedNCT02169596Phase 4
- ONSET and OFFSET of Ticagrelor in ESRDCompletedNCT02163954Phase 3
- Optical Coherence Tomography to Evaluate Ticagrelor and ClopidogrelCompletedNCT02140801Phase 4
- Comparison of Ticagrelor And Clopidogrel on Inflammatory Biomarkers And Vascular Endothelial FunctionStatus unknownNCT02123004Phase 4
- Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease PatientsWithdrawnNCT02121288Phase 4
- DIAMOND - Dual Antiplatelet Therapy to Reduce Myocardial InjuryCompletedNCT02110303Phase 2/3
- Effect of Ticagrelor on Fractional Flow ReserveCompletedNCT02108808Phase 4
- Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive ManagementCompletedNCT02094963Phase 4
- Clopidogrel And Ticagrelor in Healthy SubjectsCompletedNCT02086903Phase 3
- Triple vs. Dual TherapyCompletedNCT02080858Phase 1
- Study of Effects of Ticagrelor on Microparticles and Micro-RNA in NSTE-ACSTerminatedNCT02071966Phase 4
- Compare Ticagrelor vs Clopidogrel on the Reduction of Arterial Stiffness and Wave Reflectionsin Patients With CAD.CompletedNCT02071212Phase 2
- The Efficacy of Ticagrelor on Abdominal Aortic Aneurysm (AAA) ExpansionCompletedNCT02070653Phase 2
- Genotyping Guided Individualized Treatment of Clopidogrel and Ticagrelor in ACSStatus unknownNCT02048228Phase 2/3
- Comparing Ticagrelor and Clopidogrel Pharmacodynamics After ThrombolysisWithdrawnNCT02048085Phase 4
- OraL Crushed and dIspersed Ticagrelor 180mg Compared to Whole Tablets of eQUal Dose in STEMI Patients unDergoing Primary PCI: a Pharmacokinetic/Pharmacodynamic Study (the LIQUID Study)CompletedNCT02046486Phase 4
- A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding RiskCompletedNCT02044146Phase 2/3
- Paradigm Shift in the Treatment of Patients With ACSCompletedNCT02041650Phase 4
- Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary SyndromeTerminatedNCT02037412Phase 4
- Comparison of Clopidogrel and Ticagrelor on Microvascular Dysfunction in ST-Segment Elevation Myocardial InfarctionCompletedNCT02026219Phase 4
- Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Angina, NSTEMI and STEMI Undergoing PCIStatus unknownNCT02012140Phase 4
- Ticagrelor and AdenosineCompletedNCT01996735Phase 4
- Genotype Guided Versus Conventional Approach in Selection of Oral P2Y12 Receptor Blocker in Chinese Patients Suffering From Acute Coronary SyndromeCompletedNCT01994941Phase 4
- Ticagrelor Loading Dose Versus Clopidogrel Loading and Reloading With Ticagrelor.CompletedNCT01961856Phase 3
- Differential Effect of Ticagrelor Versus Prasugrel Maintenance Dose on Endothelial Function of Peripheral Vessels in Patients With Coronary Artery DiseaseCompletedNCT01957540Phase 4
- OPTImal Management of Antithrombotic Agents: OPTIMA-2 TrialCompletedNCT01955200Phase 4
- Ticagrelor vs High Dose Clopidogrel in Patients With ST Elevation Myocardial Infarction Post FibrinolysisCompletedNCT01950416Phase 4
- Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary SyndromeCompletedNCT01944800Phase 4
- Ticagrelor for PCI Post ThrombolysisCompletedNCT01930591Phase 3
- Comparison of Clopidogrel Versus Ticagrelor Therapy for Atherosclerotic Plaque InflammationCompletedNCT01905566Phase 4
- Ticagrelor vs Clopidogrel Effect on MFR in CAD PopulationCompletedNCT01894789Phase 2/3
- Study to Investigate if the Uptake of Ticagrelor Into the Body Differs Depending on Method of Administration.CompletedNCT01887626Phase 1
- Targeting Platelet-Leukocyte Aggregates in Pneumonia With TicagrelorCompletedNCT01883869Phase 1
- PKPD Study of Ticagrelor and Prasugrel in Healthy Korean MalesCompletedNCT01876797Phase 1
- Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy With TicagrelorStatus unknownNCT01869309Phase 4
- The Antiplatelet and Immune Response TrialCompletedNCT01846559Phase 4
- Comparison of Ticagrelor Versus Clopidogrel on Residual Thrombus Burden During PCI: an OCT StudyWithdrawnNCT01826175Phase 4
- Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet TherapyStatus unknownNCT01823185Phase 4
- Efficacy and Safety Study of TicagrelorStatus unknownNCT01812330Phase 3
- Antithrombotic Triple Therapy in HumansCompletedNCT01812200Phase 4
- Effect of Ticagrelor on Endothelial FunctionCompletedNCT01805596Phase 3
- Rapid Activity of Platelet Inhibitor Drugs Study 2CompletedNCT01805570Phase 4
- A Clinical Study of Safety and P2Y12 Receptor Inhibition Effects of Ticagrelor and Clopidogrel in Vietnamese PatientWithdrawnNCT01757262Phase 3
- Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABGTerminatedNCT01755520Phase 3
- Study to See if Platelet Transfusion Stop or Lessen the Effect of the Drug on PlateletsCompletedNCT01744288Phase 1
- Ticagrelor and Intracoronary Morphine in Patients Undergoing Primary Percutaneous Coronary InterventionStatus unknownNCT01738100Phase 2
- Antiplatelet Effects of Ticagrelor Versus Clopidogrel in American Indian PatientsCompletedNCT01706510Phase 4
- Endothelium, Stenting, and Antiplatelet Therapy (EST) - Clopidogrel, Prasugrel, Ticagrelor StudyCompletedNCT01700322Phase 4
- Comparison of Antiplatelet Effect of Ticagrelor vs Tirofiban in Patients With Non-ST Elevation Acute Coronary SyndromeStatus unknownNCT01660373Phase 3
- Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to ClopidogrelStatus unknownNCT01643031Phase 4
- Differential Effect of Ticagrelor Versus Prasugrel on the Adenosine-induced Coronary Vasodilatory Responses in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary InterventionCompletedNCT01642966Phase 4
- Τicagrelor Versus Prasugrel in Diabetic Patients: a Pharmacodynamic StudyCompletedNCT01642940Phase 4
- Study to Assess the Pharmacokinetics of AZD6140 After Single Dose in Healthy Japanese Male VolunteersCompletedNCT01588626Phase 1
- Standard (180mg) Versus Double (360mg) Loading Dose of Ticagrelor in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)CompletedNCT01575795Phase 4
- High Clopidogrel Dose Versus Prasugrel and Ticagrelor in High Reactive Stable PatientsCompletedNCT01543932Phase 3
- PraSugrel vs TicagrElor in ST-Elevation Myocardial Infarction paTients With Diabetes MellitusCompletedNCT01531114Phase 3
- Ticagrelor in Clopidogrel Resistant Patients Undergoing Chronic HemodialysisCompletedNCT01511471Phase 3
- Rapid Activity of Platelet Inhibitor Drugs StudyCompletedNCT01510171Phase 4
- Study to Assess Effect of Cyclosporine on the Blood Levels of TicagrelorCompletedNCT01504906Phase 1
- Ticagrelor in Comparison to Prasugrel for Early Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)CompletedNCT01463163Phase 4
- Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function TestingStatus unknownNCT01456364Phase 4
- Ticagrelor and Aspirin for the Prevention of Cardiovascular Events After Coronary Artery Bypass SurgeryCompletedNCT01373411Phase 4
- Ticagrelor Versus Prasugrel in Acute Coronary Syndromes After Percutaneous Coronary InterventionCompletedNCT01360437Phase 3
- Evaluation of the Drug-drug Interaction Between Ticagrelor and Venlafaxine When Taken Together in Healthy VolunteersCompletedNCT01350921Phase 1
- Study to Assess the Effect of Ticagrelor on Coronary Blood Flow in Healthy Male Subjects.CompletedNCT01226602Phase 1
- Uric Acid Study in Healthy Male VolunteersCompletedNCT00738842Phase 1
- Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy VolunteersCompletedNCT00733265Phase 1
- An Open-Label, Single and Multiple Dose Pharmacokinetic Study of 90 mg and 180 mg Doses of AZD6140 in Healthy VolunteersCompletedNCT00721448Phase 1
- AZD6140 Oral Contraceptive Interaction StudyCompletedNCT00685906Phase 1